By Elizabeth Earin
Digital pathology initiatives rarely slow down because the technology does not work. More often, they slow down because the evaluation shifts from broad strategy to detailed operational review.
Early conversations focus on long-term goals such as improving turnaround time, enabling collaboration across locations, and modernizing workflow infrastructure. There is general agreement that digital capability is becoming foundational, and early momentum reflects a shared understanding that modernization is no longer optional.
As the evaluation deepens, however, digital pathology adoption challenges become more visible as integration requirements are examined in detail, financial assumptions are tested against operational data, and additional stakeholders introduce new technical and risk considerations. The conversation gradually shifts from strategic possibility to measurable operational impact.
This stage is normal. From here, progress depends on whether or not there is a clear and structured path forward.
Below are the most common points where momentum slows — and what to do about them.
1. Integration Becomes Operational
In the early stages of evaluation, integration is typically discussed at a high level. There is an assumption that systems will connect, images will transfer reliably, and digital workflows can be incorporated into existing processes without significant disruption.
As the evaluation progresses, those assumptions need to be tested against the reality of your environment. The team must confirm how the platform will integrate with the current LIS version, how existing scanner models will be supported, and how cases will move from accessioning through review and sign-out within a digital environment. Storage architecture, authentication protocols, reporting workflows, and data retention policies must be reviewed in the context of actual case volume. IT evaluates bandwidth capacity, security requirements, disaster recovery planning, and long-term scalability.
At this stage, integration is no longer a general capability; it is a set of operational dependencies that must function reliably within your infrastructure.
How to Move Forward
To prevent integration from becoming a late-stage obstacle, requirements should be documented early in the implementation process.
These discussions should include the LIS environment and versioning, scanner inventory and compatibility, case routing logic, storage configuration, authentication standards, and reporting workflows. Discussing these requirements with your IMS vendor ensures that technical validation is structured and deliberate rather than reactive.
Your IMS vendor has the expertise and experience to walk through these discussions and provide the coaching and partnership to provide options that will work best for your goals and a newly defined digital process.
2. ROI Shifts from Vision to Proof
As evaluation progresses, financial scrutiny increases. Agreement that digital pathology is strategically important is no longer enough; leadership needs to agree on what will change in measurable terms and how those changes will determine a successful implementation.
Some benefits are strategic rather than directly financial. Expanded access to subspecialty expertise, improved collaboration across sites, and greater flexibility in case distribution may strengthen the organization, and they can have an immediate impact on reducing expenses.
At the same time, reasonable concerns arise about potential productivity shifts during transition, consistency of adoption across the group, and whether projected efficiencies will increase under expanded case volumes.
When measurable success criteria are not defined in advance, ROI discussions tend to continue without leading to a clear definition and therefore lack the ability to be properly measured and determined.
How to Move Forward
Financial and operational expectations should be clearly defined and communicated among your internal staff.
Financial expectations should include total capital investment, ongoing costs, infrastructure impact, and anticipated productivity changes. Operational expectations should focus on measurable workflow inefficiencies that exist today, including slide transport time between sites, retrieval, additional stain and recut delays, manual case reassignment, and consultation turnaround time.
Establish a baseline for these areas and identify three to five measurable outcomes that must improve within the first year. When these thresholds are documented prior to implementation, the ROI discussion shifts from open-ended analysis to structured validation.
3. Alignment Gaps Surface
As more stakeholders become involved in the evaluation, differences in priorities naturally become more visible. Clinical leadership may concentrate on diagnostic quality and confidence in digital review. Laboratory operations may focus on throughput, staffing stability, and case distribution efficiency. IT evaluates integration, security, infrastructure resilience, and long-term system reliability, while executive leadership examines financial exposure, risk tolerance, and strategic timing. Choosing a cloud-based vendor can mitigate many of these risks.
These perspectives are not inherently conflicting, but they are often unaligned. When each group measures success differently, discussions tend to broaden rather than narrow, and evaluation moves sideways instead of toward a clear decision.
How to Move Forward
Hold a focused alignment session and ask one question:
What must be true 12 months after implementation for this to be considered successful?
The responses should be documented and reviewed collectively. Differences in expectations should be addressed directly and resolved through discussion rather than left implicit. Establishing a shared definition of success reduces repetitive conversations, aligns on primary goals, eliminates the “ask for everything and the kitchen sink” approach and clarifies what still needs to be validated before a final decision is made.
The Risk of Staying in Evaluation
Conducting a thorough evaluation of a digital pathology solution is responsible. It is a decision that affects clinical workflow, infrastructure, and long-term operational gains. The risk does not come from careful review. It comes from allowing evaluation to continue without a defined path to what your organization considers success.
While conversations continue, daily operations remain unchanged. Slides still move between sites. Consults still require manual coordination. Case distribution still depends on manual processes, and individual intervention rather than system design. The pressures that prompted the search for image management software remain embedded in the workflow.
Over time, teams adapt. Departments introduce temporary tools, adjust processes locally, or redistribute cases manually to manage immediate demands. These adjustments are practical, but they are not strategic. They address pain points in the short term while making enterprise-wide standardization more difficult later and do not support scalability. What could have been implemented as a coordinated digital framework becomes more complex to align across sites.
The goal is not to accelerate a decision prematurely. It is to ensure that evaluation leads to a clear outcome. Without defined timelines and ownership, workflow constraints remain embedded in daily operations. With them, the organization can move forward deliberately, knowing what it expects to change and how success will be measured.
